Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase JAK2 | ||
Ligand | BDBM324634 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | JAK Enzyme Assays | ||
Ki | 0.300±n/a nM | ||
Citation | Cheng, Y; Hua, R; Kellar, T; Li, W; Gibbons, P; Zak, ME Therapeutic compounds, compositions and methods of use thereof US Patent US10189836 Publication Date 1/29/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase JAK2 | |||
Name: | Tyrosine-protein kinase JAK2 | ||
Synonyms: | JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase) | ||
Type: | Protein | ||
Mol. Mass.: | 130684.68 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O60674 | ||
Residue: | 1132 | ||
Sequence: |
| ||
BDBM324634 | |||
n/a | |||
Name | BDBM324634 | ||
Synonyms: | 1-[4-(2- methylsulfanylethyl)- piperazin-1-yl]-2-[4-[[8- [8-[3-(trifluoromethyl)- cyclobutanecarbonyl]-3,8- diazabicyclo[3.2.1]octan- 3-yl]-[1,2,4]triazolo[1,5-a] pyridin-2- yl]amino]pyrazol-1- yl]ethanone | US10189836, Example 197 | US10189836, Example 198 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H39F3N10O2S | ||
Mol. Mass. | 660.757 | ||
SMILES | CSCCN1CCN(CC1)C(=O)Cn1cc(Nc2nc3c(cccn3n2)N2CC3CCC(C2)N3C(=O)C2CC(C2)C(F)(F)F)cn1 |(-12.99,1.1,;-11.75,.19,;-10.34,.81,;-9.1,-.11,;-7.69,.51,;-6.45,-.4,;-5.04,.21,;-4.87,1.74,;-6.11,2.66,;-7.52,2.04,;-3.45,2.36,;-3.28,3.89,;-2.21,1.45,;-.8,2.07,;-.47,3.57,;1.06,3.72,;1.84,5.05,;3.38,5.05,;4.29,3.81,;5.75,4.28,;7.08,3.52,;8.42,4.29,;8.41,5.83,;7.08,6.6,;5.75,5.82,;4.28,6.3,;7.09,1.98,;5.76,1.2,;5.76,-.34,;6.37,.51,;7.82,.52,;8.43,-.33,;8.42,1.21,;7.09,-1.1,;7.1,-2.64,;5.77,-3.42,;8.43,-3.41,;8.84,-4.9,;10.32,-4.49,;9.92,-3.01,;11.66,-5.26,;10.89,-6.6,;12.43,-3.93,;12.99,-6.03,;1.68,2.31,;.53,1.29,)| | ||
Structure |